Melrose Internal Medicine is categorized under Internal Medicine Doctors in Melrose, MA and active since 1976.
Melrose Internal Medicine was established in 1976, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Neal W Nadelson at the company’s single location by writing to 50 Rowe St # 500, Melrose, Massachusetts MA 02176 or by phoning (781) 979-3800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Melrose Internal Medicine |
| Contact Person: | Neal W Nadelson |
| Address: | 50 Rowe St # 500, Melrose, Massachusetts 02176 |
| Phone Number: | (781) 979-3800 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1976 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Melrose Internal Medicine was started in 1976 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Neal W Nadelson for inquiries that concern Melrose Internal Medicine by calling the company number (781) 979-3800, as your correspondence is most welcome. Additionally, the physical location of the single location of Melrose Internal Medicine can be found at the coordinates 42.45885,-71.06058 as well as the street address 50 Rowe St # 500 in Melrose, Massachusetts 02176.
For its online presence, you may visit Melrose Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.